Amlodipine, Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 68180-771

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Amlodipine, Valsartan And Hydrochlorothiazide (NDC 68180-771). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

111922d9 0549 464b 8b1f D8240a5f7900 01

Chemical structure diagram showing molecular components, including a chlorobenzene ring, an ester group, and a sulfonic acid group, consistent with chemical representations often related to the active ingredients amlodipine, valsartan, or hydrochlorothiazide in the product.*

FDA Label Image

111922d9 0549 464b 8b1f D8240a5f7900 02

Chemical structure diagram of the active ingredient Amlodipine, showing its molecular arrangement with labeled atoms and bonds.*

FDA Label Image

111922d9 0549 464b 8b1f D8240a5f7900 03

Chemical structure diagram of the active ingredient Hydrochlorothiazide, showing its molecular composition with labeled atoms and bonds.*

FDA Label Image

111922d9 0549 464b 8b1f D8240a5f7900 04

A bar chart comparing the effects of different drug combinations on diastolic and systolic blood pressure (BP). The x-axis labels different treatments: HCTZ/Aml 25/10, Val/HCTZ 320/25, Aml/Val 10/320, and Aml/Val/HCTZ 10/320/25. The y-axis shows BP change values, with bars indicating reductions in diastolic and systolic BP for each treatment.*

FDA Label Image

111922d9 0549 464b 8b1f D8240a5f7900 05

A line graph comparing mean sitting diastolic blood pressure (DBP) over eight weeks for different treatments of Amlodipine, Valsartan, and Hydrochlorothiazide combinations. The x-axis represents weeks, and the y-axis shows mean sitting DBP in mmHg. Four treatment groups are plotted with distinct markers and lines.*

FDA Label Image

111922d9 0549 464b 8b1f D8240a5f7900 06

Line chart showing mean sitting systolic blood pressure (SBP) over 8 weeks with different treatments: Amlodipine/Valsartan/Hydrochlorothiazide (Aml/Val/HCTZ) 10/320/25 mg, Amlodipine/Val 10/320 mg, Val/HCTZ 320/25 mg, and HCTZ/Aml 25/10 mg. Blood pressure decreases over time with various rates per treatment.*

FDA Label Image

111922d9 0549 464b 8b1f D8240a5f7900 07

A line graph depicting mean ambulatory diastolic blood pressure (DBP) in mmHg over 24 hours after dosing. The chart compares several treatments: Amlodipine/Val/HCTZ at 10/320/25 mg, Val/HCTZ 320/25 mg, Amlodipine/Val at 10/320 mg, and HCTZ/amlodipine at 25/10 mg, showing the blood pressure trends throughout the day.*

FDA Label Image

111922d9 0549 464b 8b1f D8240a5f7900 08

A line graph displaying mean ambulatory systolic blood pressure (SBP) in mmHg over 24 hours post-dosing. The x-axis shows time in hours after dosing from 0 to 24, and the y-axis shows mean SBP values approximately from 110 to 140 mmHg. Four treatment groups are shown with distinct symbols representing different combinations and dosages of Amlodipine, Valsartan, and Hydrochlorothiazide.*

FDA Label Image

111922d9 0549 464b 8b1f D8240a5f7900 09

Label for Amlodipine, Valsartan and Hydrochlorothiazide Tablets USP, 5 mg/160 mg/12.5 mg strength, film-coated tablets. The label indicates a package of 30 tablets by Lupin Pharmaceuticals, Inc., manufactured by Lupin Limited in India. Includes storage instructions and active ingredient quantities per tablet.*

FDA Label Image

111922d9 0549 464b 8b1f D8240a5f7900 10

Label for Amlodipine, Valsartan and Hydrochlorothiazide Tablets USP 10 mg/160 mg/12.5 mg film-coated tablets. The label indicates the package contains 30 tablets, is Rx only, and is manufactured for Lupin Pharmaceuticals, Inc., Baltimore, Maryland, by Lupin Limited, Goa, India. Dosage and storage instructions are included, with a barcode and NDC 68180-772-06 visible.*

FDA Label Image

111922d9 0549 464b 8b1f D8240a5f7900 11

Label for Amlodipine, Valsartan and Hydrochlorothiazide Tablets USP 5 mg/160 mg/25 mg in film-coated tablet form, supplied in a package of 30 tablets. Manufactured by Lupin Limited, India, and distributed by Lupin Pharmaceuticals, Inc. The label includes storage instructions and dosage references, with barcode and NDC 68180-773-06.*

FDA Label Image

111922d9 0549 464b 8b1f D8240a5f7900 12

Packaging label for Amlodipine, Valsartan and Hydrochlorothiazide Tablets USP, strength 10 mg/160 mg/25 mg, film-coated oral tablets. The label indicates a package size of 30 tablets. It shows the NDC 68180-774-06 and manufacturer Lupin Pharmaceuticals, Inc., Baltimore, Maryland, with manufacturing by Lupin Limited in Goa, India. The label includes storage instructions and dosage reference to prescribing information.*

FDA Label Image

111922d9 0549 464b 8b1f D8240a5f7900 13

Label for Amlodipine, Valsartan and Hydrochlorothiazide Tablets USP, film-coated, strength 10 mg/320 mg/25 mg, in a package of 30 tablets. Manufactured for Lupin Pharmaceuticals, Inc. The label includes dosage and storage instructions, a barcode, and manufacturer details for Lupin Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.